Psoriatic hyperplasia: some measurements.

PubWeight™: 1.05‹?› | Rank: Top 15%

🔗 View Article (PMID 5453259)

Published in Br J Dermatol on January 01, 1970

Authors

E Christophers, O Braun-Falco

Articles by these authors

A peptide antibiotic from human skin. Nature (1997) 7.64

Isolation and characterization of human beta -defensin-3, a novel human inducible peptide antibiotic. J Biol Chem (2000) 6.19

Purification and partial biochemical characterization of a human monocyte-derived, neutrophil-activating peptide that lacks interleukin 1 activity. J Immunol (1987) 4.43

Disease concomitance in psoriasis. J Am Acad Dermatol (1995) 3.92

Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils. J Exp Med (1992) 3.20

Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris. J Am Acad Dermatol (1985) 2.74

Evidence for two psoriasis susceptibility loci (HLA and 17q) and two novel candidate regions (16q and 20p) by genome-wide scan. Hum Mol Genet (1997) 2.48

Elafin: an elastase-specific inhibitor of human skin. Purification, characterization, and complete amino acid sequence. J Biol Chem (1990) 2.23

Elevated levels of NAP-1/interleukin-8 are present in the airspaces of patients with the adult respiratory distress syndrome and are associated with increased mortality. Am Rev Respir Dis (1992) 2.11

Structure determination of a human lymphocyte derived neutrophil activating peptide (LYNAP). Biochem Biophys Res Commun (1988) 2.10

Linkage analysis of human leukocyte antigen (HLA) markers in familial psoriasis: strong disequilibrium effects provide evidence for a major determinant in the HLA-B/-C region. Am J Hum Genet (1998) 2.09

Annular erythema associated with Sjögren's syndrome: a variant of systemic lupus erythematosus. J Am Acad Dermatol (1991) 2.07

Secretion of novel and homologous neutrophil-activating peptides by LPS-stimulated human endothelial cells. J Immunol (1989) 2.04

The human peripheral lymphocyte--a model system for studying the combined effect of psoralen plus black light. Klin Wochenschr (1977) 1.97

Identification of C5ades arg and an anionic neutrophil-activating peptide (ANAP) in psoriatic scales. J Invest Dermatol (1986) 1.96

The ABCD rule of dermatoscopy. High prospective value in the diagnosis of doubtful melanocytic skin lesions. J Am Acad Dermatol (1994) 1.94

[Electron microscopic studies on the dynamics of acantholysis in pemphigus vulagaris. I. The clinically normal appearing skin in the environment of blisters with a positive Nikolski phenomenon]. Arch Klin Exp Dermatol (1965) 1.94

Localization of psoriasis-susceptibility locus PSORS1 to a 60-kb interval telomeric to HLA-C. Am J Hum Genet (2000) 1.86

The genetics of psoriasis. Arch Dermatol (1994) 1.84

Structural aspects of initial psoriatic lesions. Arch Dermatol Forsch (1974) 1.81

Localization of neutrophil-activating peptide-1/interleukin-8-immunoreactivity in normal and psoriatic skin. J Invest Dermatol (1991) 1.79

[Electron microscopic studies on the dynamics of acantholysis in pemphigus vulgaris. II. The acantholytic vesicle]. Arch Klin Exp Dermatol (1965) 1.75

Mutations in cornea-specific keratin K3 or K12 genes cause Meesmann's corneal dystrophy. Nat Genet (1997) 1.75

Treatment of psoriasis with fumaric acid esters: results of a prospective multicentre study. German Multicentre Study. Br J Dermatol (1998) 1.67

Dose-effects of 8-methoxypsoralen and UVA in cultured human lymphocytes. Br J Dermatol (1978) 1.64

[Dynamics of normal and pathological hair growth]. Arch Klin Exp Dermatol (1966) 1.62

[On the problem of optimal reacting conditions in the histochemical demonstration on enzymes of the energy-delivering metabolism in the epidermis. I. Dehydrogenase]. Arch Klin Exp Dermatol (1965) 1.60

[Microstructure of the epidermis in chronic nummular eczema. I. Stratum basale]. Arch Klin Exp Dermatol (1965) 1.54

[Postoperative adjuvant therapy with interferon alfa-2B following laser surgery of condylomata acuminata]. Hautarzt (1990) 1.54

Lipopolysaccharide-stimulated human monocytes secrete, apart from neutrophil-activating peptide 1/interleukin 8, a second neutrophil-activating protein. NH2-terminal amino acid sequence identity with melanoma growth stimulatory activity. J Exp Med (1990) 1.53

IL-1 alpha or tumor necrosis factor-alpha stimulate release of three NAP-1/IL-8-related neutrophil chemotactic proteins in human dermal fibroblasts. J Immunol (1990) 1.50

[Stimulation of epidermal DNA syntgesis through vitamin A acid]. Arch Klin Exp Dermatol (1968) 1.48

Dithranol: a review of the mechanism of action in the treatment of psoriasis vulgaris. Skin Pharmacol (1990) 1.43

[Safety margins in the excision of primary malignant melanoma. Proposals based on controlled clinical trials]. Hautarzt (2001) 1.42

Skin tumors in the European PUVA Study. Eight-year follow-up of 1,643 patients treated with PUVA for psoriasis. J Am Acad Dermatol (1987) 1.42

Purification and partial biologic characterization of a human lymphocyte-derived peptide with potent neutrophil-stimulating activity. J Immunol (1988) 1.42

Late irradiation damage to the skin caused by soft X-ray radiation therapy of cutaneous tumors. Arch Dermatol (1995) 1.41

In situ localization of IgG in epidermolysis bullosa acquisita by immunogold technique. J Am Acad Dermatol (1992) 1.40

[Abnormal behavior of epidermal regeneration in patients with psoriasis vulgaris]. Arch Klin Exp Dermatol (1967) 1.39

Semiquantitative analysis of histologic criteria in thin malignant melanomas. J Am Acad Dermatol (1989) 1.38

[Cryofibrinogenemia caused by monoclonal anti-fibrinogen antibodies]. Dtsch Med Wochenschr (1996) 1.38

[Merkel cell tumor of the skin]. Dtsch Med Wochenschr (1997) 1.38

[Virus-specific antibody profile in various stages of HIV-1 infection. Western blot analysis of 170 patients]. Klin Wochenschr (1988) 1.38

[Epidermal regeneration of guinea pig's ear following the tearing off of the horny layer. A radioautographic study]. Arch Klin Exp Dermatol (1967) 1.38

Cellular architecture of the stratum corneum. J Invest Dermatol (1971) 1.37

Prognostic index in malignant melanoma. Arch Dermatol (1978) 1.36

Excisional biopsy as the first therapeutic procedure versus primary wide excision of malignant melanoma. Cancer (1989) 1.35

Treatment of severe psoriasis with fumaric acid esters: scientific background and guidelines for therapeutic use. The German Fumaric Acid Ester Consensus Conference. Br J Dermatol (1999) 1.34

[Inflammatory infiltrate in psoriasis vulgaris. A cytochemical study]. Arch Klin Exp Dermatol (1970) 1.33

Mast cells and macrophages in early relapsing psoriasis. Arch Dermatol Res (1985) 1.31

Quadrant distribution of dysplastic nevus syndrome. Arch Dermatol (1988) 1.28

Epidemiology and comorbidity of psoriasis in children. Br J Dermatol (2009) 1.27

[Current aspects of the pathogenesis of skin manifestations in psoriasis vulgaris]. Hautarzt (1976) 1.27

What is the 'true' function of skin? Exp Dermatol (2002) 1.26

[Modification of epidermal differentiation by vitamin A acid. Electron microscopy study]. Arch Klin Exp Dermatol (1970) 1.25

[On DNA synthesis time in the human epidermis]. Arch Klin Exp Dermatol (1967) 1.25

Initial events in psoriasis: quantitative assessment. Br J Dermatol (1973) 1.24

[A new method for visualization of the stratum corneum]. Arch Klin Exp Dermatol (1970) 1.24

[Growth dynamics of epidermis and papillary bodies after local applications of vitamin A acid. Biometrical studies of the guinea pig ear]. Arch Klin Exp Dermatol (1968) 1.24

Binding to human jejunum of serum IgA antibody from children with coeliac disease. Lancet (1990) 1.22

Mechanisms of parakeratosis. Br J Dermatol (1970) 1.22

Proliferative cells in the human sebaceous gland. Labelling index and regional variations. Acta Derm Venereol (1971) 1.21

Detection of circulating melanoma cells by specific amplification of tyrosinase complementary DNA is not a reliable tumor marker in melanoma patients: a clinical two-center study. J Clin Oncol (1997) 1.20

IL-4 induces eotaxin: a possible mechanism of selective eosinophil recruitment in helminth infection and atopy. J Immunol (1998) 1.20

[The effect of dithranol in psoriasis fulgaris. Cyto- and histochemical investigations]. Arch Dermatol Forsch (1971) 1.20

[Histochemistry of capillaries in psoriasis vulgaris]. Arch Klin Exp Dermatol (1970) 1.19

Association of rare human papillomavirus types with genital premalignant and malignant lesions. J Infect Dis (1998) 1.19

Scanning chromosome 17 for psoriasis susceptibility: lack of evidence for a distal 17q locus. Hum Hered (1995) 1.17

Neutrophil-activating proteins in psoriasis. J Invest Dermatol (1992) 1.17

Antileukoprotease in human skin: an antibiotic peptide constitutively produced by keratinocytes. Biochem Biophys Res Commun (1998) 1.17

Benign symmetric lipomatosis Launois-Bensaude. Report of ten cases and review of the literature. J Am Acad Dermatol (1987) 1.17

[The morphogenesis of senile actinic elastosis. An electron microscopic study]. Arch Klin Exp Dermatol (1969) 1.16

[Normal pH value of human skin]. Hautarzt (1986) 1.16

[Electron microscopic studies of the dynamics of blister formation in bullous pemphigoid]. Arch Klin Exp Dermatol (1967) 1.15

[On the histotopy of enzymes of energy producing metabolism in the epidermis in psoriasis vulgaris]. Arch Klin Exp Dermatol (1967) 1.15

The genetics of psoriasis 2001: the odyssey continues. Arch Dermatol (2001) 1.14

[Distribution of acid phosphatase in normal and psoriatic keratinization. (Electron microscopic and cytochemical studies)]. Dermatologica (1967) 1.14

[Trichostasis spinulosa]. Hautarzt (1967) 1.13

Importance of human papillomaviruses for the development of skin cancer. Cancer Detect Prev (2001) 1.13

A classification of psoriasis vulgaris according to phenotype. Br J Dermatol (2007) 1.13

S100B protein detection in serum is a significant prognostic factor in metastatic melanoma. Oncology (1999) 1.12

[Demonstration of circulating soluble immune complexes in the sera of psoriatic patients using the 125I-C1q deviation test]. Hautarzt (1977) 1.12

[On histochemical enzyme demonstration in skin pathogenic fungi. II. Dermatophytes]. Arch Klin Exp Dermatol (1966) 1.11

[Histochemical and cytochemical investigations in allergic DNCB-contact dermatitis of the guinea pig]. Arch Klin Exp Dermatol (1970) 1.11

[Unusual adverse effects of oral photochemotherapy (PUVA-therapy) in psoriasis]. Hautarzt (1977) 1.11

Chimaeric CD4 monoclonal antibody in treatment of generalised pustular psoriasis. Lancet (1991) 1.11

[On the enzymatic organization of the energy producing metabolism of normal guinea pig skin. 3. Activity determination of epidermal enzymes of the citric acid cycle and associated reactions]. Arch Klin Exp Dermatol (1966) 1.10

[On quantitative assessment of histochemical dehydrogenase demonstrations]. Histochemie (1965) 1.10

Polymorphonuclear leukocyte chemotaxis in psoriasis: enhancement by self-activated serum. Br J Dermatol (1980) 1.10

Occurrence of IgE-bearing epidermal Langerhans cells in atopic eczema: a study of the time course of the lesions and with regard to the IgE serum level. J Invest Dermatol (1989) 1.09

[On the thickness of collagen fibrils in the embryonal skin]. Z Zellforsch Mikrosk Anat (1967) 1.09

The dermal inflammatory reaction in initial psoriatic lesions. Arch Dermatol Res (1977) 1.09